Literature DB >> 11283003

Residues within the N-terminal domain of human topoisomerase I play a direct role in relaxation.

M Lisby1, J R Olesen, C Skouboe, B O Krogh, T Straub, F Boege, S Velmurugan, P M Martensen, A H Andersen, M Jayaram, O Westergaard, B R Knudsen.   

Abstract

All eukaryotic forms of DNA topoisomerase I contain an extensive and highly charged N-terminal domain. This domain contains several nuclear localization sequences and is essential for in vivo function of the enzyme. However, so far no direct function of the N-terminal domain in the in vitro topoisomerase I reaction has been reported. In this study we have compared the in vitro activities of a truncated form of human topoisomerase I lacking amino acids 1-206 (p67) with the full-length enzyme (p91). Using these enzyme forms, we have identified for the first time a direct role of residues within the N-terminal domain in modulating topoisomerase I catalysis, as revealed by significant differences between p67 and p91 in DNA binding, cleavage, strand rotation, and ligation. A comparison with previously published studies showing no effect of deleting the first 174 or 190 amino acids of topoisomerase I (Stewart, L., Ireton, G. C., and Champoux, J. J. (1999) J. Biol. Chem. 274, 32950-32960; Bronstein, I. B., Wynne-Jones, A., Sukhanova, A., Fleury, F., Ianoul, A., Holden, J. A., Alix, A. J., Dodson, G. G., Jardillier, J. C., Nabiev, I., and Wilkinson, A. J. (1999) Anticancer Res. 19, 317-327) suggests a pivotal role of amino acids 191-206 in catalysis. Taken together the presented data indicate that at least part(s) of the N-terminal domain regulate(s) enzyme/DNA dynamics during relaxation most probably by controlling non-covalent DNA binding downstream of the cleavage site either directly or by coordinating DNA contacts by other parts of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283003     DOI: 10.1074/jbc.M010991200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro.

Authors:  Morten O Christensen; Hans U Barthelmes; Fritz Boege; Christian Mielke
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

2.  Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics.

Authors:  G Chillemi; M Redinbo; A Bruselles; A Desideri
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

Review 3.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

4.  Calcium-induced cleavage of DNA topoisomerase I involves the cytoplasmic-nuclear shuttling of calpain 2.

Authors:  Shang-Min Chou; Ting-Hsiang Huang; Hsiang-Chin Chen; Tsai-Kun Li
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

5.  DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.

Authors:  Christine M Wright; Marié van der Merwe; Amanda H DeBrot; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

6.  Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the N terminus in clamp closure.

Authors:  Komaraiah Palle; Luca Pattarello; Marié van der Merwe; Carmen Losasso; Piero Benedetti; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2008-08-08       Impact factor: 5.157

7.  A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.

Authors:  Sourav Saha; Chiranjit Acharya; Uttam Pal; Somenath Roy Chowdhury; Kahini Sarkar; Nakul C Maiti; Parasuraman Jaisankar; Hemanta K Majumder
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

8.  Role of a tryptophan anchor in human topoisomerase I structure, function and inhibition.

Authors:  Gary S Laco; Yves Pommier
Journal:  Biochem J       Date:  2008-05-01       Impact factor: 3.857

9.  Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing Plasmodium parasites based on enzyme activity measurement.

Authors:  Sissel Juul; Christine J F Nielsen; Rodrigo Labouriau; Amit Roy; Cinzia Tesauro; Pia W Jensen; Charlotte Harmsen; Emil L Kristoffersen; Ya-Ling Chiu; Rikke Frøhlich; Paola Fiorani; Janet Cox-Singh; David Tordrup; Jørn Koch; Anne-Lise Bienvenu; Alessandro Desideri; Stephane Picot; Eskild Petersen; Kam W Leong; Yi-Ping Ho; Magnus Stougaard; Birgitta R Knudsen
Journal:  ACS Nano       Date:  2012-11-07       Impact factor: 15.881

10.  Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin.

Authors:  Marié van der Merwe; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2007-12-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.